Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001258693-26-000015

CHIEF EXECUTIVE OFFICER sold 18,198 shares at an average $55.63 ($1,012,375)

  • CHIEF EXECUTIVE OFFICER acquired 16,198 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

PICKERING GRANT · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-27 Exercise or conversion : show line 1 in the form 10b5-1 +16,198 $2.03 $32,882 469,445 D
2026-07-27 Sale : show line 2 in the form 10b5-1 −11,783 $55.52 $654,133 457,662 D
2026-07-27 Sale : show line 3 in the form 10b5-1 −4,415 $55.93 $246,935 453,247 D
2026-07-27 Sale : show line 4 in the form 10b5-1 −756 $55.52 $41,970 133,459 I
2026-07-27 Sale : show line 5 in the form 10b5-1 −244 $55.96 $13,655 133,215 I
2026-07-27 Sale : show line 6 in the form 10b5-1 −622 $55.54 $34,546 133,593 I
2026-07-27 Sale : show line 7 in the form 10b5-1 −378 $55.91 $21,135 133,215 I
Open-market sales · 18,198 sh · avg $55.63 · $1,012,375

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-27 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) −16,198 137,000 D
Loading xslF345X06/wk-form4_1785269436.xml…